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Abstract
Wilms’ Tumor 1 (WT1) is a transcription
factor involved in the development of the uro-
genital system. The purpose of this study was
to analyze the immunoreactivity for WT1 pro-
tein in different tissues and organs in human
fetuses in early phases of gestation. To this
end, samples from multiple organs were
obtained from 4 human fetuses, ranging from
7 up to 12 weeks of gestation. Each sample was
formalin-fixed, paraffin embedded and
immunostained for WT1. Our data show that
WT1 is involved in development of multiple
human organs in a more vast series of cells
types than previously reported. Immuno -
staining for WT1 was characterized by a pre-
dominant cytoplasmic reactivity in the vast
majority of cell types. Mesenchimal progeni-
tors in the fetal lung, ductal plate progenitors
in fetal liver, cap mesenchimal cells in the
developing kidney, fetal zone cells in adrenal
glands, atrial and ventricular cardiomyocytes
in the fetal heart, radial glial cells in the fetal
cerebral cortex and skeletal muscle cell precur-
sors showed the highest levels of WT1
immunoreactivity. Future studies will be need-
ed to detect differences in the expression of
WT1 in various organs at different gestational
ages, in order to better evaluate the role of
WT1 in cell proliferation and differentiation
during intrauterine human development.
Introduction
The Wilms’ Tumor 1 (WT1) protein is a zinc
finger transcription factor encoded by the
human gene WT1 which has a length of ~50 kb
and consists of 10 exons.1 WT1 shares a high
degree of structural homology with the early
growth response (EGR) transcription factor
family2,3 and it is involved in the onset of
Wilms’ tumor, the most common primary renal
tumor in childhood.4 The combination of alter-
native splicing of mRNA5 and RNA editing6 can
generate more than 20 different gene prod-
ucts. The corresponding proteins, which are
designated as WT1 (-KTS) and WT1 (+KTS)
respectively, differ in the selective domain for
DNA binding. Isoforms WT1 (-KTS) are potent
transcriptional activators and preferentially
bind to DNA, whereas the isoforms WT1
(+KTS) have a role in RNA binding.7 The WT1
protein regulates the transcription of numer-
ous genes and functions both as activator and
as transcriptional co-activator or as repressor
of gene expression.8 Thanks to the ability of
the WT1 to bind RNA, it can also be detected in
the cytoplasm of many cells. A significant per-
centage of cytoplasmic WT1 is observed in
association with the ribonucleoprotein parti-
cles (RNPs), strengthening the hypothesis of
its involvement in RNA metabolism.9 In addi-
tion, WT1 is associated with polysomes active
in the translation, opening the possibility of its
involvement in the regulation of translation.10
Due to its role as a transcription factor, WT1
recognizes genes promoters containing a DNA
sequence rich in GC, including c-myc,11
EGR1,12 WT113 and PAX2.14 Recently, it has been
shown that even the genes promoters for
nephrin,15 nestin,16 trkB,17 SF1,18
amphiregulin,17 Bcl2,11 vitamin D receptor,20,21
podoxalyxin22 may represent physiological tar-
gets of WT1. WT1 is involved in development of
several tissues, including early developing kid-
ney,23,24 in which it plays a role in both the
induction of angioblasts and the regulation of
angiogenesis. WT1 has been one of the first
tumor suppressor genes identified for playing
a role in kidney development25 and it is consid-
ered a master control gene that regulates the
expression of a large number of genes that
play a critical role in early phases of nephroge-
nesis. Embryogenesis of the kidneys is
induced by a reciprocal interaction of the
metanephric mesenchyme and the invading
ureteric bud.26 WT1 is upregulated since the
mesenchyme begins to condensate around the
ureteric bud tips. In the absence of WT1, the
mesenchyme becomes apoptotic and invasion
of the ureteric bud does not occur, suggesting
that WT1 acts as a survival factor for embryon-
ic kidney progenitor cells. During the later
stages of renal development, WT1 may inhibit
mesenchymal cell proliferation, thereby allow-
ing the formation of S-shaped bodies, which
will elongate and eventually connect to the
branching collecting duct tree, giving rise to
the mature nephrons.27
WT1 protein was initially shown as a marker
of stem cells in the mouse embryo.28 Recently,
a study from our group showed that WT1 is
strongly expressed in the stem/progenitor cells
of the human fetal kidney.29 Evidences show-
ing the expression of WT1 protein during nor-
mal kidney development at different stages of
nephrogenesis suggest a possible role for WT1
in mesenchymal-epithelial transition (MET),
as well as in the development and maturation
of podocytes.29 Recent studies have shown that
WNT signaling pathway is a major target of
WT1.30 WT1 probably negatively regulates
WNT/β-catenin signaling during kidney devel-
opment.31 Moreover, WT1 plays a complex role
in the regulation of cell proliferation and apop-
tosis.32 Recently, studies based on silencing
WT1 by RNA interference have demonstrated
the critical role played by WT1 in these
processes that regulate the fetal  development
as well as tumor development.33 A large num-
ber of studies on the expression of WT1 pro-
tein in different tissues and cell types during
embryogenesis were performed in mice mod-
els. In these experiments, the expression of
WT1 was restricted to specific cell types, most
of which undergo MET during organogenesis.34
Recently, it has been suggested a potential role
of WT1 protein in the development of the nerv-
ous tissues in mouse, including retina and
retinal ganglia35 and of the olfactory system.36
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Moreover, a strong WT1 cytoplasmic immunos-
taining in developing skeletal and cardiac mus-
cle cells, in endothelial cells, in the sympathetic
system and in the gastroenteric nervous system
has been reported in human fetuses.37-38 The
purpose of this study was to analyze the WT1
immunoreactivity in different tissues and
organs in human fetuses during early phases
of development, and to assess its possible role
in human ontogeny.
Materials and Methods
The expression of WT1 was evaluated in
several tissues from four human fetuses that
we received from the Obstetric Division of the
University of Cagliari, as voluntary termina-
tion of pregnancy (VTOP). All the fetuses
included in this study had no congenital mal-
formation. All procedures performed were
approved by the Ethics Human Studies
Committee of University Medical Centre of
Cagliari (according to the instructions of the
Declaration of Helsinki).
The fetuses, aged from 7th to 12th week of
gestation (Table 1), have been completely sam-
pled and histologically and immunohistochem-
ically studied. Samples were fixed in 10%
buffered formalin, routinely processed, and
paraffin-embedded. Two serial 3 µm-thick sec-
tions were obtained from each paraffin block;
after dewaxing and rehydrating, one of these
was stained with hematoxylin-eosin, the other
pre-treated for immunohistochemical analysis,
with 10 min heat-induced epitope retrieval in
buffer pH 9.00 (EnVisionTM FLEX Target
Retrieval Solution High pH, Code: K8004; Dako
Denmark A/S, Glostrup, Denmark). Slides were
then incubated for 20 min at room tempera-
ture with anti Wilms’ Tumor (WT1) (Code:
M3561; Dako North America, Carpinteria, CA,
USA) mouse monoclonal antibody clone 6F-H2
at 1:100 dilution. Staining procedures were
performed by EnvisionTM FLEX+ (Code: K8002;
Dako Denmark A/S) Detection System and
AutostainerLink 48 instrument following deal-
er’s instructions. The data were obtained by
evaluation of positivity (+) and negativity (-)
for WT1 immunoreactivity in the various tis-
sues and organs (Table 1).
Results
Placental WT1 cytoplasmic immunoreactivi-
ty was restricted to two main cell types: muscu-
lar cells in the arterial wall and star-shaped
cells in close relationship with the cytotro-
phoblast. 
No significant reactivity for WT1 was detect-
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Table 1. Clinical and immunohistochemical data.
                                                                Case 1         Case 2         Case 3         Case 4
Gender                                                                               mv                     M                       F                       M
Gestational age (weeks)                                                 7                        9                       11                     12
Body weight (g)                                                               mv                      3                       12                     14
Placenta                                                                                
       Cito-trophoblast                                                         -                       mv                      -                        -
      Sincitio-trophoblast                                                  -                       mv                      -                        -
      Endothelial cells                                                       +                      mv                     +                      +
      Interstitial cells                                                         +                      mv                     +                      +
      Corion of villi                                                              +                      mv                     +                      +
Gut
       Lamina propria                                                         mv                      +                      +                      +
      Enterocytes                                                                 -                         -                        -                        -
      Submucosa                                                                  -                        +                      +                      +
      Myoenteric plexus                                                    +                       +                      +                      +
      Tonaca muscularis propria                                      +                        -                        -                        -
Kidney                                                                                   
       Glomerular Podocyte                                               +                       +                      +                      +
      Proximal and distal tubules                                     -                         -                        -                        -
      Cap mesenchyme cells                                           mv                      +                      +                      +
      Metanephtic mesenchyme                                    mv                      +                      +                      +
      Collecting tubules                                                    mv                       -                        -                        -
      Capsular parietal epithelium                                mv                      +                      +                      +
Adrenal glands                                                                    
       Fetal zone                                                                  mv                      +                      +                      +
      Definitive zone                                                          mv                       -                        -                        -
      Capsule                                                                       mv                      +                      +                      +
Lung                                                                                      
       Mesenchymal cells                                                  mv                      +                      +                      +
      Ephitelial cells                                                          mv                       -                        -                        -
      Pleura                                                                          mv                      +                      +                      +
Heart                                                                                     
       Atrial cardiomyocytes                                               +                       +                      +                      +
      Ventricular cardiomyocytes                                    +                       +                      +                      +
      Endocardium                                                              -                         -                        -                        -
      Epicardium                                                                 +                       +                       -                        -
Liver                                                                                      
       Hepatocyte                                                                  -                         -                        -                        -
      Kupffer cells                                                             mv                       -                        -                        -
      Hematopoietic cells                                                  -                         -                        -                        -
      Ductal cells                                                                  -                         -                       +                      +
      Sinusoidal cells                                                          +                       +                      +                      +
Central nervous system                                                   
       Cerebral cortex                                                        mv                      +                      +                      +
      Spinal cord                                                                 mv                      +                      +                      +
      Neural progenitor cells                                           +                       +                      +                      +
Skeletal muscle                                                                +                      +                      +                      +
Smooth muscle                                                                 -                        -                        -                        -
Cartilage                                                                            mv                      -                        -                        -
Skin                                                                                        
       Epidermis                                                                  mv                       -                        -                        -
      Derma                                                                         mv                      +                      +                      +
Gonads                                                                                 
       Testis                                                                          mv                      +                     mv                       
      Ovary                                                                           mv                                                                      -
mv, missing value; +,  positivity;  -, negativity.
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ed in both cyto- and sincitio-trophoblast
(Figure 1). In the fetal gut, immunostaining
for WT1 was detected in the cytoplasm of lami-
na propria of the mucosa, being particularly
strong along the fibrovascular axis of villi, in
the absence of any significant reactivity in the
enterocytes. A cytoplasmic expression of WT1
were also observed in the submucosa and in
the myoenteric plexus. No immunoreactivity
for WT1 was found in the smooth muscle cells
of the tonaca muscularis propria (Figure 2
A,B). In the developing fetal kidney, reactivity
for WT1 was observed in different cell types
and in different renal compartments. At
panoramic view, immunostaining for WT1 was
mainly located in the developing glomeruli, in
the nephrogenic zone located under the renal
capsule and in interstitial cells (Figure 3A). At
higher magnification, proximal, distal and col-
lecting tubules were completely negative, as
well as the immature mesenchymal cells
merged in a loose connective tissue located in
the hilar regions. Staining for WT1 was detect-
ed in the cytoplasm of the interstitial cells sur-
rounding tubular structures (Figure 3B).
Inside glomeruli, WT1 was expressed in the
cytoplasm of podocyte precursors and along the
developing basal membranes. Reactivity for
WT1 was also observed inside the nuclei of
podocyte precursors, contrasting with the
absence of immunostaining in the mesangial.
No significant reactivity was detected in the
parietal epithelial cells (Figure 3C). The study
of the renal capsule evidenced a peculiar pat-
tern regarding WT1 immunoreactivity. We
found a marked variability among different
capsular cells, WT1 being expressed only by
scattered cells. Immunostaining was found in
the cytoplasm of the cells of the nephrogenic
zone, both in non-induced metanephric cells
and in the Cap mesenchymal cells surrounding
the tips of the branching ureteric bud. In the S-
shaped bodies, WT1 preferentially immunos-
tained the cytoplasm of podocyte progenitors.
Reactivity for WT1 was also observed in spin-
dle cells located in the renal interstitium
(Figure 3D). In the fetal adrenal glands, cyto-
plasmic immunoreactivity for WT1 was mainly
located in the cytoplasm of cells of the fetal
zone, contrasting with the absence of reactivi-
ty in the definitive zone located under the
adrenal capsule. A pattern similar to that
observed in the renal capsule was also found in
the cytoplasm of adrenal capsule cells, with
some strongly reactive capsular cells intermin-
gled with non-reactive cells. A strong cytoplas-
mic immunostaining was also found in the
wall of the adrenal vessels (Figure 4). In the
developing lung, cytoplasmic immunoreactivi-
ty for WT1 was restricted to mesenchymal cells
and in the pleura, while the epithelial cells lin-
ing the branching tubules did not show any
immunostaining. In particular, WT1 was
expressed in the developing vessels, in close
proximity to the tubular structures. In the pul-
monary arteries, a strong cytoplasmic reactivi-
ty for WT1 was found around the arterial
lumen (Figure 5).  In the fetal heart,
immunoreactivity for WT1 was characterized
by striking differences among different cardiac
compartments (Figure 6). The highest levels of
cytoplasmic immunostaining for WT1 were
observed in the muscle cells of the atria. A
weaker immunoreactivity was detected in the
cytoplasm of cardiomyocytes of both ventricles.
No significant staining was observed in the
wall of the large arteries emerging from the
heart (Figure 6). In the developing human
liver, WT1 was not expressed in the hepato-
cytes, in Kupffer cells nor in hematopoietic
cells. A mild reactivity for WT1 was observed in
the cytoplasm of mesenchymal cells of the
developing portal tracts. WT1 was also
expressed in the cytoplasm of cells of develop-
ing biliary structures, including remnants of
the ductal plate (Figure 7). In the fetal brain,
WT1 was expressed in the cerebral cortex
(Figure 8A). Reactivity for WT1 were detected
in the cytoplasm of Radial Glia cells involved in
guiding the radial migration of developing
neuronal precursor from the ventricular zone
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Figure 1. WT1 immunostaining in placenta. WT1 immunoreactivity was restricted to
cytoplasm of muscular cells in the arterial wall (black arrow) and star-shaped cells in close
relationship with the cytotrophoblast (red arrows).
Figure 2. WT1 immunostaining in fetal gut. WT1 was detected A) in the cytoplasm of
lamina propria of the mucosa and in the fibrovascular axis of villi (black arrows); B) in
the submucosa (red arrow).
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toward the marginal zone. Immunostaining for
WT1 was also detected in afferent axonal
fibers extending from the thalamus toward
cerebral cortex, establishing synaptic contacts
between neuronal precursor of the sublate
zone. WT1 has been observed to be expressed
in the cytoplasm of developing Radial Glia cells
in the Spinal cord (Figure 8B). Cytoplasmic
immunoreactivity for WT1 were observed in
developing skeletal muscles (Figure 9A). The
developing skin was characterized by a con-
trast between the absence of immunostaining
in the epidermis and the cytoplasmic positivity
observed in the progenitor cells of the develop-
ing derma (Figure 9B). A cytoplasmic
immunostaining for WT1 was also detected in
endothelial cells of blood vessels. No reactivity
was found in superficial (epidermis, GI tract,
endometrium, renal tubules, urothelium) and
glandular (salivary glands, thyroid, pancreas,
ovary) epithelia; biliary cells were the unique
epithelial cells expressing WT1 in this study.
No immunoreactivity for WT1 was detected in
thymus, smooth muscle tissue, crystalline
lens, cartilage and blood cells.
Discussion 
In recent years, many studies carried out on
experimental animal models have shown that
WT1 protein plays a key role in embryonic
development. WT1 has been involved in the
development of the urogenital system, particu-
larly during early kidney development.25 Other
studies on mice models have shown that WT1
is involved in the development of spleen39 and
adrenal glands.40 Studies on knock-out mice
showed that WT1 is required for heart develop-
ment27 and for the development of the central
nervous system, retina35 and the olfactory sys-
tem.36 Few studies performed on human
embryonic and fetal tissues showed that WT1
is involved in the development of human kid-
ney23 and female and male gonads.41 WT1
expression was detected in nuclei of some
fetal tissues including metanephros and
mesonephros, spleen, gonads, peritoneal
mesothelium,42 skeletal muscle, smooth mus-
cle of urinary bladder, ureter and arteries.43
Previous immunhistochmical studies utilizing
antibodies against C-terminal of WT1 protein
showed a predominant nuclear localization of
this transcription factor in several developing
organs.34,41-43 As compared to these previous
studies, our work was based on the use of anti-
WT1 monoclonal antibody specific for the N-
terminal portion of this protein (clone 6F-H2).
This new available antibody is able to detect
both cytoplasmic and nuclear reactivity.35-38
These localizations reflect the important role
of WT1 as a nuclear transcription factor and its
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Figure 3. WT1 immunostaining in fetal kidney. WT1 immunoreactivity was detected A)
in the developing glomeruli (black arrows) and in the nephrogenic zone located under
the renal capsule (red arrow); B)  in the cytoplasm of interstitial cells surrounding tubu-
lar structures (black arrow); C) in the cytoplasm and nuclei of podocyte precursors (black
arrows) and along the developing basal membranes inside glomeruli (red arrow); and D)
in the cytoplasm of Cap mesenchimal cells (black arrows) and in spindle cells located in
the renal interstitium (red arrow).
Figure 4. WT1 immunostaining in fetal adrenal gland. WT1 immunoreactivity was locat-
ed in the cytoplasm of cells of the fetal zone and in the adrenal capsule, with some strong-
ly reactive capsular cells intermingled with non-reactive cells (F, fetal zone; D, definitive
zone; C, adrenal capsule). 
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involvement in RNA metabolism and in the
regulation of translation. Our study adds new
data regarding a major role of WT1 in develop-
ing human organs, tissues and cell types. By
an immunohistochemical approach, we
demonstrated that in the developing embryo
and fetus, WT1 is expressed in various human
organs, in which WT1 immunoreactivity was
not reported by previous studies. In the fetal
lung, WT1 was expressed in the pleura and in
mesenchymal progenitors surrounding
branching epithelial structures (Figure 5).
Moreover, WT1 immunostaining was detected
in small vessels inside the pulmonary scarcely
differentiated mesenchyme. Recent studies
conducted on transgenic mouse models have
shown an involvement of WT1  in the develop-
ment of this organ, suggesting a major role for
WT1 in pleura and lung development.44,45 At
the best of our knowledge, our data represent
the first report of WT1 involvement in human
lung morphogenesis, and confirm the rele-
vance of its expression even in human lung
development. The high immunoreactivity
detected in developing small vessels surround-
ing the epithelial structures may indicate a
role for WT1 in the formation of the peri-alve-
olar capillaries. 
WT1 immunoreactivity in the liver was
restricted to portal tracts, while hepatocytes
and hematopoietic cells appeared non-
immunoreactive for WT1 protein. Inside portal
tracts, only specific cell types expressed WT1,
including stromal cells, muscular cells of the
portal vein and arterial wall, bile ductular cells
and developing ductal cells of the ductal plate
(Figure 7). Inside the liver acinus, a focal
immunoreactivity for WT1 was detected in the
cytoplasm of isolated sinusoidal cells. These
findings lay stress on a possible relevant role
for WT1 in the development of the biliary tree.
The strong expression of WT1 protein in the
cells of the ductal plate as well as in the cells of
the developing biliary structures observed at
the periphery of immature portal tracts sug-
gests a role for WT1 at least in the early phases
of the development of the human biliary tree.
On the basis of these preliminary data, further
studies are needed in order to better analyze
WT1 expression and its role in the more
advanced stages of maturation of the intrahep-
atic and extrahepatic biliary tree, as well as
during the progression of vanishing bile duct
diseases in childhood. Regarding WT1 expres-
sion in the developing kidney, our data confirm
previous studies on a major role played by WT1
during kidney development.25,39 In all fetal kid-
neys immunostained, WT1 immunoreactivity is
extended from the nephrogenic zone to the
capsule, the residual metanephric mes-
enchyme and to the vast majority of glomeruli
(Figure 3). Regarding the renal cell types
expressing WT1, the protein was mainly detect-
ed in the cytoplasm of immature stem/precur-
sor cells, including a subset of intracapsular
cells and the majority of metanephric mes-
enchymal cells detectable at the renal hilum.
Inside the nephrogenic zone, WT1 was prefer-
entially expressed by cap mesenchymal cells
aggregating around the tips of the branching
ureteric bud. These data confirm previous
reports from our group on a preferential WT1
expression in stem/progenitors of the develop-
ing human kidney and, in particular, in stem
cells undergoing mesenchymal-epithelial tran-
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Figure 5. WT1 immunostaining in fetal lung. WT1 was expressed in cytoplasm of mes-
enchymal progenitors surrounding branching epithelial structures (black arrows) and in
small vessels inside the pulmonary scarcely differentiated mesenchyme (red arrow). 
Figure 6. WT1 immunostaining in fetal heart. Atrial cardiomyocytes (black arrow)
showed higher cytoplasmic levels of WT1 immunostaining as compared to those
observed in both ventricles (red arrow). 
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sition such as the Cap mesenchymal cells.29
WT1 was also detectable in a specific differen-
tiated glomerular cell: the podocyte. This find-
ing suggests a role for WT1 not restricted to the
early phases of kidney development, but also in
the differentiation process of podocytes, as pre-
viously reported.29 Further studies are manda-
tory in order to better analyze the role of WT1 in
podocyte development in the different phases
of kidney development, as well as during the
insurgence of podocytopathies in childhood
and in adult subjects. 
A new finding emerging from our study is
represented by the detection of a reactivity for
WT1 in the human fetal adrenal glands (Figure
4). Previous studies had reported the involve-
ment of WT1 in the development of adrenal
glands in mice, without defining the cell type
involved in WT1 expression. Here we describe,
at the best of our knowledge for the first time,
a preferential WT1 expression in a single cell
type of the developing human adrenal glands,
the cells of the fetal zone, in the absence of any
significant reactivity in the cells of the defini-
tive zone (Figure 4). The meaning of this
expression in fetal zone cells is not clear. The
association of WT1 expression in a subset of
cells inside the adrenal capsule, putatively rep-
resenting adrenal stem/progenitor cells, leads
to hypothesize that WT1 might be mainly
involved in the early phases of adrenal devel-
opment, its role decreasing in more differenti-
ated adrenal cells, including cells of the defin-
itive zone. 
Interesting data emerge, in this study, from
the analysis of WT1 expression in the develop-
ing fetal heart. The involvement of WT1 in
heart development had been previously report-
ed in mice.27 In humans, a single study showed
a strong WT1 cytoplasmic immunostaining in
developing cardiac muscle cells.37 In this study,
we confirm the high levels of WT1 protein
expression in cardiac cells in the fetal hearts
studied. Regarding the cell type involved in
WT1 expression, cardiomyocytes appeared as
the site of the WT1 immunostaining.
Moreover, differences were found regarding
the level of WT1 expression in the different
compartments of the developing heart. Atrial
cardiomyocytes showed higher levels of
immunostaining as compared to those
observed in both ventricles (Figure 6). The
immunostaining of atria and ventricles con-
trasted with the absence of reactivity in the
large vessels emerging from the heart.
Moreover, we detected WT1 immunostaining
in epicardial cells, whereas no reactivity for
the protein was found in endocardial cells.
These data taken together indicate a complex
pattern of WT1 expression in the developing
human heart, with decreasing levels of WT1
expression from atrial cardiomyocytes to ven-
tricle cardyomyocytes to the epicardium, end-
                                                                                                        Original Paper
Figure 7. WT1 immunostaining in fetal liver. WT1 cytoplasmic immunoreactivity was
observed in the of mesenchymal cells of the developing portal tracts (black arrows) and
developing biliary structures (red arrows), including remnants of the ductal plate (green
arrow). 
Figure 8. WT1 immunostaining in fetal central nervous system. WT1 was detected A) in
the cytoplasm of  Radial glia and in the axons localized in the cerebral cortex (VZ, ven-
tricular zone; MZ,  marginal zone) and B) in the cytoplasm of Radial Glia of the spinal
cord. 
Figure 9. WT1 immunostaining in fetal arts. WT1 cytoplasmic immunoreactivity were
observed A) in developing skeletal muscles and B) in the progenitor cells of the develop-
ing derma (black arrow).
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ing with the absence of the expression of
endocardium and large vessel cells. This spec-
trum of WT1 expression in the developing
human heart deserves further studies in order
to better specify the role of WT1 in the differ-
ent cardiac cell types during the different
phases of heart development.
A recent study on WT1 expression in the
human developing gut showed WT1 expression
to be restricted to the sympathetic neuroblasts
of the fetal gastro-enteric nervous system, pro-
gressively decreasing with differentiation of
these cells along both ganglionic and chromaf-
fin cell lineage.38 In our study, WT1 expression
was found in the myoenteric plexus of the fetal
gut confirming the finding of Parenti et al.
Moreover, we detected high levels of WT1 in
the lamina propria of the fetal gut and particu-
larly in the fibrovascular axis of the intestinal
villi (Figure 2). WT1 expression in muscularis
propria was observed in one case, the 7-week-
old fetus, suggesting a role for WT1 restricted
to the very early phases of gut muscular cells
development. The involvement of WT1 in cen-
tral nervous system development had been pre-
viously reported in the human fetus.38 Our
study confirm a possible relevant role for WT1
in the development of the human central nerv-
ous system. The reactivity of WT1 was detected
in radial glia cells in the cerebral cortex and in
the spinal cord (Figure 8). The finding of reac-
tivity for WT1 in radial Glia cells, the primary
progenitors capable of generating neurons,
astrocytes and oligodendrocytes46 suggest the
involvement of WT1 in the early phases of
development of multiple cell lineages in CNS.
Since neuronal precursor use radial Glia as
scaffold in order to reach their final destina-
tion,47 our data indicate that WT1 plays a role
not only in differentiation but even in cell
migration. In this study, WT1 immunostaining
were also detected in developing skeletal mus-
cle cells (Figure 9A), confirming previous
reports.37 This finding suggest a major role for
WT1 in the development of human skeletal
muscle, and deserves further studies on WT1
expression in these cells during the more
advanced stages of the intrauterine develop-
ment.
In conclusion, our study clearly indicates
that WT1 is involved in development of a large
number of human organs, tissues and cell
types, suggesting a critical role in the early
phases of morphogenesis of the majority of
human organs. Further studies are needed in
order to better analyze the immunohistochem-
ical and the mRNA expression pattern of WT1
in the different phases of human development,
in order to better understand the role of WT1 in
the differentiation of human cell types in the
perinatal period and the post-natal life.
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